Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group - Nabholtz, J M; Buzdar, A; Pollak, M (J Clin Oncol, 2000)